BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1994590)

  • 1. Are the acid-labile interferon alpha and interferon omega-1 identical?
    Kontsek P; Borecký L; Novák M
    Virology; 1991 Mar; 181(1):416-8. PubMed ID: 1994590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies and enzyme immunoassays specific for human interferon (IFN) omega 1: evidence that IFN-omega 1 is a component of human leukocyte IFN.
    Adolf GR
    Virology; 1990 Apr; 175(2):410-7. PubMed ID: 1691561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic structure of human interferon omega 1 (interferon alpha II1): comparison with other human interferons.
    Adolf GR
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1669-76. PubMed ID: 2438379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porcine leukocyte interferon exhibits close antigenic relatedness to human interferon alpha 2, but not to human interferon alpha 1.
    Karayianni-Vasconcelos G; Borecký L; Kontsek P
    Vet Immunol Immunopathol; 1993 Oct; 38(3-4):359-65. PubMed ID: 7507275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human acid- and thermolabile alpha-interferon-like substance: selective reactivity with a monoclonal antibody.
    Borecký L; Kontsek P; Novák M; Lackovic V
    Antiviral Res; 1989 Nov; 12(4):195-203. PubMed ID: 2619284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of the antigenic structure of human interferon alpha-2 by PH 2 treatment: a further support for the antigenic relationship between alpha and beta interferons.
    Kontsek P; Borecký L; Koniseková E; Novák M; Krchnák V
    Acta Virol; 1990 Apr; 34(2):145-54. PubMed ID: 1698015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies neutralizing human leukocyte acid- and thermolabile interferon alpha.
    Kontsek P; Borecký L; Lackovic V; Kontseková E; Sujanová Z; Novák M
    Acta Virol; 1989 May; 33(3):254-61. PubMed ID: 2570512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct effect of pH 2 on a common antigenic structure found in human interferons-alpha 1 and -alpha 2 in the region 30-35.
    Kontsek P; Borecký L; Novák M; Kontseková E; Máciková I; Krchnák V
    J Interferon Res; 1991 Dec; 11(6):327-32. PubMed ID: 1724779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic characterization of recombinant, lymphoblastoid, and leukocyte IFN-alpha by monoclonal antibodies.
    Viscomi GC; Antonelli G; Bruno C; Scapol L; Malavasi F; Funaro A; Simeoni E; Pestka S; De Pisa F; Dianzani F
    J Interferon Cytokine Res; 1999 Apr; 19(4):319-26. PubMed ID: 10334382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemical mapping of alpha-2 interferon.
    Lydon NB; Favre C; Bove S; Neyret O; Benureau S; Levine AM; Seelig GF; Nagabhushan TL; Trotta PP
    Biochemistry; 1985 Jul; 24(15):4131-41. PubMed ID: 2413884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological activity of human alpha-interferons studied using specific antisera].
    Korsun NS; Nosik DN; Novokhatskiĭ AS; Trushinskaia GN
    Antibiot Khimioter; 1988 Nov; 33(11):827-30. PubMed ID: 2465745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral action of tumor necrosis factor in human fibroblasts is not mediated by B cell stimulatory factor 2/IFN-beta 2, and is inhibited by specific antibodies to IFN-beta.
    Reis LF; Le JM; Hirano T; Kishimoto T; Vilcek J
    J Immunol; 1988 Mar; 140(5):1566-70. PubMed ID: 3279118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of antigenic domains on natural and recombinant human IFN-beta by the inhibition of biologic activities with monoclonal antibodies.
    Redlich PN; Grossberg SE
    J Immunol; 1989 Sep; 143(6):1887-93. PubMed ID: 2476486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human interferon omega--a review.
    Adolf GR
    Mult Scler; 1995; 1 Suppl 1():S44-7. PubMed ID: 9345398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitive antiproliferative neutralization assay for the detection of neutralizing IFN-alpha and IFN-beta antibodies.
    Prümmer O; Streichan U; Heimpel H; Porzsolt F
    J Immunol Methods; 1994 May; 171(1):45-53. PubMed ID: 8176238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different interactions of interferon-alpha subtypes at the surface of epithelial and lymphoid cells.
    Overall ML; Chambers P; Hertzog PJ
    J Interferon Res; 1992 Aug; 12(4):281-8. PubMed ID: 1431308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino acid substitutions in loop BC and helix C affect antigenic properties of helix D in hybrid IFN-alpha21a/alpha2c molecules.
    Schmeisser H; Hu R; Kontsek P; Bekisz J; Zoon K
    J Interferon Cytokine Res; 2002 Apr; 22(4):463-72. PubMed ID: 12034029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid-labile interferon produced in human peripheral leukocytes by induction with Sendai virus.
    Matsuoka H; Kakui Y; Tanaka A; Cho Y; Imanishi J
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2491-4. PubMed ID: 2997378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities.
    Ozes ON; Reiter Z; Klein S; Blatt LM; Taylor MW
    J Interferon Res; 1992 Feb; 12(1):55-9. PubMed ID: 1573283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A type I ovine interferon with limited similarity to IFN-alpha, IFN-omega and IFN-tau: gene structure, biological properties and unusual species specificity.
    Liu L; Leaman DW; Bixby JA; Roberts RM
    Biochim Biophys Acta; 1996 May; 1294(1):55-62. PubMed ID: 8639714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.